Where does Codex DNA, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Codex DNA, Inc. ranks #22,395 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Codex DNA, Inc. hold?

Codex DNA, Inc. holds 12 US utility patents granted between 2020 and 2023, spanning 12 technology areas.

What is Codex DNA, Inc.'s Innovation Score?

Codex DNA, Inc. has an Innovation Score of 33.8 out of 100 (46th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Codex DNA, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Codex DNA, Inc..

What does claim depth mean for Codex DNA, Inc.'s patents?

Codex DNA, Inc.'s patents average 17.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Codex DNA, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Codex DNA, Inc.

Q: What technology areas does Codex DNA, Inc. focus on?

Codex DNA, Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 11 patents, ranking #932 of 4,144 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

USPTO PatentsView assignee record - 12 granted patents across 12 technology areas, recorded in grant years 2020–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Codex ranks #22,395 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 12 technology areas.

#22,395
of 49,997 US assignees by volume: 46th percentile
by Innovation Score (33.8/100): 17.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R22395 · US Corporation #22,395 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 12 grants
MID-PACK #22,395/49,997
PHOTO-FINISH Climate Master
CPC-FOCUS C12N · 12 areas
INNOV-THIN 33.8/100
CLAIMS-RICH 17.5 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2023 · 4y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Climate Master, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Codex’s 33.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (26%) Velocity 2.2 pts (7%) Breadth 12.2 pts (36%) Claim depth 10.5 pts (31%)

Qualcomm Incorporated · highest

85
Codex DNA · this assignee

34
3D Lighting… · lowest

7

What this shows Codex's Innovation Score is 33.8/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Codex?

Each dot is one of Codex’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Codex’s own 17.5 claims/patent is ABOVE the 17.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Codex vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Codex's grants concentrate

Codex DNA, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 91.7% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2021 (6 grants) versus a trough of 1 in 2023. By volume, Codex sits between Climate Master, Inc. and Combis Sport Enterprise Co., Ltd..

Codex's three-year grant acceleration

Codex DNA, Inc. shows 3 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Climate Master

12
Cloudsight

12
Coda Therapeutics

12
Codebroker

12
Cognixion

12
Cohen Concepts

12
Combinati Incorpo…

12
Combis Sport Ente…

12
Codex DNA ◀

12

What this shows Codex holds 12 patents at rank #22,417, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Codex

By rank, the assignees closest to #22,417 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Codex's primary technology class.

Codex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 46th percentile higher than 46% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Codex DNA, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	3	25.0%
2021	6	50.0%
2022	2	16.7%
2023	1	8.3%

Which technologies does Codex DNA, Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 11

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

C12Y - Enzymes 4

C07K - Peptides 2

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

G06F - Electric Digital Data Processing 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Codex DNA, Inc.'s patent record in context - here's where to go next.

Codex DNA, Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 91.7% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #22,395 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Codex DNA, Inc. against Climate Master, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.